Abstract-A micropower, high-resolution biopotential data acquisition circuit for wireless and implantable medical instrumentation is presented. The circuit is an incremental ∆Σ (BioADC) that accepts inputs directly from recording electrodes and serves as both amplifier and digitizer with just a single OTA at the core. Auto-ranging and precise digital gain control allow the BioADC to accommodate input ranges of 1mV to 30mV with DC offset rejection. The hybrid amplifier/ADC achieves up to 12 bits of resolution, a sampling rate of 2.048kHz and an input referred noise of 2.65µV rms at a power consumption of 20µW . The bioamplifier achieves a noise efficiency factor of 3.1. Live physiological ECG data are shown, acquired by connecting passive Ag/AgCl electrodes directly to the BioADC input.
I. INTRODUCTION
Wireless and implantable biomedical devices are becoming increasingly important for healthcare and research. Wearable, unobtrusive ECG/EEG systems allow patients to screen their vital signs for abnormalities during their daily lives. High density multi-channel implantable neural electrodes benefit researchers in understanding the nervous system and will be integral to future neuroprosthetics to help the disabled. Advancements in ultra-low power, integrated circuits has is a key driving force in this field.
The analog front-end consisting of the amplifier and ADC is a one major component in a biopotential acquisition system. For miniature wireless battery powered devices, minimizing the power and complexity of the analog front-end is still a challenge.
To date, several authors have built innovative integrated solutions for multi-channel biopotential recordings using the approach of a low noise preamplifier [1] followed by an ultralow power SAR [2] or ∆Σ ADC [3] . It is possible to achieve excellent noise efficiency specifications [4] [5] [6] as well as very high channel densities [7] .
In addition, single chip, commercial multi-channel ECG/EEG products have also appeared on the market with very high resolution, but a relatively large power consumption of around 1mA/channel. [8] However, nearly all currently known bioamplifier circuits are designed to drive a separate ADC block, with the exception of [9] which produces pulse delay modulated output. Thus, there are two primary sources of power and complexity in the typical analog front-end. The amplifier section consumes up to several microamperes of current, and is dictated by the noise requirement. The ADC section itself will require separate circuits and will also consume up to tens of microamperes per ADC channel [3] . For future integrated systems, an even more efficient solution is desirable.
In this work, we introduce a new bioamplifier circuit that configures the OTA normally used as just as the amplifier into also functioning simultaneously as an incremental ∆Σ ADC. By integrating the amplifier within the ADC, there is no need to drive any portion of the analog front-end beyond Nyqusit rate and and an explicit anti-alias filter is not needed. The BioADC interfaces directly with unbuffered, µV levels signals from the body and provides a digitized output.
The BioADC reduces the complexity and power of the analog-front end for biopotential systems by integrating the amplification and digitization of signals into one circuit. The main source of static power dissipation is from biasing the core OTA, which sets the noise levels, the same as conventional systems. Power and area for separate, dedicated ADC circuits are eliminated. We were able to achieve a total power consumption of less than 20µW per channel without compromising on noise and resolution.
II. CIRCUIT OVERVIEW
The core of the BioADC consists ( Fig. 1 ) of an OTA, a comparator, data latches and the input coupling and feedback capacitors. Signals from a differential pair of recording electrodes are directly connected to the on-chip capacitors, C in , at the OTA's input. The comparator and feedback capacitors complete the incremental ∆Σ feedback loop. The digital output from the BioADC is taken from the comparator's latch. In this version, only the core analog circuitry is on-chip and the digital timing, control logic and biases were implemented on the test PCB.
A. Input Coupling
A reset switch is enabled only at power-up to initialize the voltage at the OTA's input to a known value, V ref . During normal operation, the input nodes of the OTA are left at a very high impedance. If unattended, leakage currents at the [10] . The OTA serves as the integrator of the incremental ∆Σ ADC. The amount of feedback from the comparator's decision applied back to the OTA input's is digitally controlled to precisely set the gain.
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To control the OTA input node voltages, two sets of increment/decrement update circuits [10] are utilized as a way to dynamically inject small amounts of correcting current. The increment/update circuits are built from a NMOS and PMOS transistor placed in parallel with their gates respectively tied close to ground.
For common mode control, the voltage at the source of the OTA input pair, V cm,in (Fig. 1 and Fig. 2) , is monitored and compared to the desired level, V in,ref . The comparator for the common-mode control circuit is a simple 1-stage OTA biased with only 50nA of current and does not contribute a significant amount of power.
Differential offsets are dynamically cancelled by monitoring the output bitstream. The direction of the charge pump (OFF+, OFF-) is controlled such a negative feedback loop is formed at low frequencies, causing the BioADC to auto-center signals over long periods of time, counteracting differential drift. In the current implementation, this effectively implements a lowpass filter of around 1Hz. In addition, different modulation patterns for the charge pump can be used to achieve various high-pass filtering characteristics. The OTA is a standard, fully-differential cascoded amplifier. The input PMOS pair was sized with an extremely large W/L (480/1.5) ratio and operated in subthreshold. All the other devices are sized to be long, and operated in strong inversion such that the noise should be dominated by the input pair alone [1] . CMFB is accomplished by taking common-mode of the output signal available at the node in-between the two integration capacitors, C int with the DC level restored during the normal reset phase of the BioADC.
The bias current of the OTA that sets the noise floor of the BioADC is nominally between .5µA and 8µA. This biasing current is normally the largest source of static power dissipation.
A latched comparator is used as the quantizer for the ∆Σ modulator and consists of two preamplifier stages followed by a positive feedback latch circuit [11] . The first and second pre-amplifier stages are capacitively coupled and reset at the same time as the OTA integrator. This dynamically cancels the comparator and OTA offset as part of each sample conversion. A total of 750nA is used to bias the latch's preamplifiers.
C. Incremental ∆Σ ADC
A first order, continuous-time, incremental ∆Σ ADC is formed through the OTA, which serves as a resettable G m − C integrator, a comparator and a negative feedback loop through
The timing diagram for one sample is shown in Figure 3 . A sample begins with a pulse (Rst) which resets C int and simultaneously nulls the comparator and OTA offset. The signal is integrated for a period of T s which ends with a pulse to latch the comparator's decision.
Depending on the integrated voltage, either D+ or D-is asserted high. Because both the inputs and comparator decision are capacitively coupled, the summing node which combines the signal and the ∆Σ negative feedback can be implemented right at the OTA's input.
The voltage at the output of the OTA integrator over one period, T s , can be written as,
where the polarity of the second term is controlled by the comparator's last decision, g m is the OTA's transconductance and C t is the sum of the capacitances at the OTA's input (including parasitics). The full scale code for the incremental ADC is set by the amount of feedback applied in the loop and is controlled by the supply voltage and the duty cycle of G (T f /T s ) resulting in full-scale input of,
(2)
A total of OSR periods is integrated and quantized before reseting the integrator. Summing the periods that D out+ is high represents a OSR-bit resolution code for the input signal over a single sample, completing the operation of the incremental ADC. The circuit cannot function reliably as a conventional ∆Σ ADC since the OTA and comparator's DC operating points need to be periodically refreshed.
The gain is ratiometric and set by the sizes of C in (15pF ) and C f (150fF ) and independent of PVT, bias current and parasitic input capacitances. The two variables that control the full-scale range of the BioADC, and hence gain, V ref (nomially set at V dd ) and the duty cycle of G (T f /T s ). Thus, the gain can be well defined and easily tuned through digital control. With the BioADC, it is possible to have full-scale input ranges of less than 1mV differential, allowing for small µV signals to be directly connected to the BioADC.
The BioADC combines the advantages of several previous implementations of bioamplifiers and ADCs, while integrating both functions with a single core analog OTA for optimal power efficiency. A typical low-noise bioamplifier [1] [3] will also consist of an OTA along with signal coupling capacitors C in and C f arranged in negative feedback to set the closed loop gain. The addition of the explicit OTA load capacitance, C int and comparator in the feedback loop, essentially operates the circuit as a class-D bioamplifier. In combination with the ∆Σ feedback, the switched output of the BioADC is directly provides a digital output.
III. CHARACTERIZATION
The fabricated chip (Fig. 7) containing two separate channels was tested for distortion and noise performance using a simple custom PCB with a USB data acquisition circuit. The chip was also connected directly to electrodes placed on a subject to collect live physiological data.
A. Distortion and Resolution
Since the BioADC is fundamentally an AC coupled system, the INL and DNL of the ADC cannot be determined from measurements.
To characterize the ADC for AC signals, a single tone test is used to measure the level of distortion. The FFT of a 100Hz, 1mV input signal is shown in Figure 4 . For this test, the BioADC was set to operate at an oversampling ratio of 2 10 which corresponded to a post decimation sample rate of 512Hz. The gain setting was set such that the full-scale code was just slightly higher than the 1mV input tone.
Overall distortion levels are low, and the BioADC achieves an ENOB of 9.5b for a 1mV full scale input.
B. Noise Performance
The ADC's noise floor was measured by shorting both differential inputs to ground and recording the output data stream. Figure 5 shows the input-referred voltage noise density for OTA bias currents of 1µA and 8µA.
The noise at low frequencies is mainly dominated by 1/f noise of the input transistors as well as noise from leakage currents from the charge pump. At higher frequencies, the levels approach the thermal noise limits of the input differential pair.
A noise efficiency factor of the ADC is 3.1 at a bias current of 1µA and a total input referred voltage noise of 2.6µV rms is measured. At a bias current of 1µA, the BioADC approaches the fundamental thermal noise floor of the subthreshold input pair showing that the addition of the ADC circuits does not significantly degrade the noise performance. The overall performance of the BioADC is comparable to the best integrated bioamplifiers reported to date.
C. Physiological Recordings
Live ECG data was acquired by connecting the differential inputs of the ADC directly to a subject's chest via purely passive Ag/AgCl electrodes (3M Red Dot). The recorded data can be seen in Fig. 6 along with a recording of an artificial ECG from a signal generator.
IV. CONCLUSION
We present a low power amplifier/ADC specifically suited for wireless and implantable biomedical devices. The biopotential acquisition circuit accepts unbuffered signals and performs both amplification and digitization using just one core OTA. Overall performance in terms of power, noise and resolution is comparable to standard bioamplifier circuits with an analog output. The BioADC provides a simple, efficient circuit to build highly integrated, multi-channel biopotential acquisition systems.
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